Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 72,787	$ 37,932
General and administrative	32,852	22,511
Total operating expenses	105,639	60,443
Loss from operations	(105,639)	(60,443)
Other income (expense), net:
Interest income, net	4,587	24
Change in fair value of the Series A redeemable convertible preferred stock tranche liability	0	(10,341)
Total other income (expense), net	4,587	(10,317)
Net loss	(101,052)	(70,760)
Unrealized loss on investments in marketable securities	(1,048)	0
Comprehensive loss	$ (102,100)	$ (70,760)
Net loss per share attributable to common stockholders-basic	$ (1.84)	$ (2.45)
Net loss per share attributable to common stockholders-diluted	$ (1.84)	$ (2.45)
Weighted-average shares used in computing net loss per share-basic	54,873,675	28,919,255
Weighted-average shares used in computing net loss per share-diluted	54,873,675	28,919,255